Ultralife (NASDAQ:ULBI – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Thursday.
Separately, Benchmark lifted their price target on shares of Ultralife from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, June 27th.
View Our Latest Research Report on Ultralife
Ultralife Trading Up 0.9 %
Ultralife (NASDAQ:ULBI – Get Free Report) last posted its quarterly earnings results on Thursday, July 25th. The technology company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08. The company had revenue of $42.98 million for the quarter. Ultralife had a net margin of 5.96% and a return on equity of 9.32%.
Institutional Investors Weigh In On Ultralife
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. ClariVest Asset Management LLC raised its holdings in Ultralife by 2.9% during the 2nd quarter. ClariVest Asset Management LLC now owns 66,657 shares of the technology company’s stock valued at $708,000 after acquiring an additional 1,864 shares during the period. Empowered Funds LLC grew its position in shares of Ultralife by 7.8% during the 1st quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after purchasing an additional 2,275 shares in the last quarter. Perritt Capital Management Inc. grew its position in shares of Ultralife by 25.0% during the 1st quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock valued at $132,000 after purchasing an additional 3,000 shares in the last quarter. Acadian Asset Management LLC grew its position in shares of Ultralife by 4.4% during the 2nd quarter. Acadian Asset Management LLC now owns 146,635 shares of the technology company’s stock valued at $1,556,000 after purchasing an additional 6,206 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Ultralife by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock valued at $4,545,000 after purchasing an additional 6,640 shares in the last quarter. Institutional investors own 30.68% of the company’s stock.
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading
- Five stocks we like better than Ultralife
- What is the S&P 500 and How It is Distinct from Other Indexes
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Best Stocks Under $10.00
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.